81. INDICES Sorbitol For Hepatic Encephalopathy INDICES sorbitol for hepatic encephalopathy. Subject INDICES sorbitol for hepaticencephalopathy; From Melanie Beaton melabeat@rph.health.wa.gov.au ; http://www.essentialdrugs.org/indices/hma/indices.199811/msg00009.php

INDICES Archives (by date) Thread Index November 28, 1998 From November 25, 1998 From : "David Newby" <mddan@cc.newcastle.edu.au> November 22, 1998 From : Nathalie_ISOUARD@barcelona.msf.org November 15, 1998 From November 14, 1998 From November 13, 1998 From : "Melanie Beaton" <melabeat@rph.health.wa.gov.au> November 12, 1998 From : "Boyce, TA, Tanya, Mrs" <tboyce@uctgsh1.uct.ac.za> November 10, 1998 From November 08, 1998 From November 07, 1998 From November 02, 1998 From : "Boyce, TA, Tanya, Mrs" <tboyce@uctgsh1.uct.ac.za> From : lo@euronet.nl From November 01, 1998 From : "Kenneth Y. Hartigan-Go" <hartigan@kulog.upm.edu.ph> From Mail converted by MHonArc

82. Article Status 2001 issue. 2001, 12, 17.1.01, hepatic encephalopathy syndromes, Withdrawn. Withdrawn.2001, 14, 17.1.01, Newer aspects hepatic encephalopathy, Withdrawn. http://www.indianjgastro.com/statuscheck_jan.htm

ARTICLE STATUS CHECK Next>> Year Number Date of receipt Title Outcome Endoscopic pancreatic...experience Rejected 14.5.01 H. pylori...in Kashmir No response- file closed 10.08.01 Correlation between...portal hypertension Rejected 30.4.01 Colonic intussusception...challenge Published July-Aug 2001 issue Impacted denture...presentation Published July-Aug 2001 issue Comparison of...guinea pigs Published Jan-Feb 2002 issue Laser palliation...cases No response- file closed 10.08.01 Spontaneous perforation...pregnancy Published Sept-Oct 2001 issue Pre and post...associated DU Published Jan-Feb 2002 issue Acute exacerbation...hepatitis B No response- file closed 15.09.01 Strongyloides...anticancer therapy Published July-Aug 2001 issue Hepatic encephalopathy syndromes Withdrawn Interplay of...poto-systemic Withdrawn Newer aspects...hepatic encephalopathy Withdrawn Sporadic intra-abdominal abdomen Withdrawn MR imaging...hepatic encephalopathy Withdrawn Nutritional support...hepatic encephalopathy

83. Welcome To The Universtity Of South Alabama Gastroenterology Continuing Educatio Blei AT, Cordoba J. Practice Guidelines hepatic encephalopathy. Am J Gastroenterol2001;9619681975. 1. hepatic encephalopathy is diagnosed by. http://www.usagiedu.com/encephaldoc.htm

GASTROENTEROLOGY LITERATURE REVIEW SESSION October 4, 2001 Blei AT, Cordoba J. Practice Guidelines: Hepatic Encephalopathy. Am J Gastroenterol 2001;96:1968-1975. 1. Hepatic encephalopathy is diagnosed by a. finding a high ammonia level in blood b. finding a high ammonia level in CSF c. excluding other causes of altered mental status in a person with cirrhosis d. finding a normal EEG in a person with cirrhosis and altered mental status e. finding asterixis in a person with cirrhosis and altered mental status True or False 2. Correlation of blood ammonia levels with mental state in cirrhosis is inaccurate, blood levels correlate poorly with brain levels. 3. Constipation can be the trigger factor for hepatic encephalopathy 4. Metronidazole 250mg bid or zinc supplementation may be added to lactulose in patients with recurrent encephalopathy 5. Eradication of H. pylori is recommended to prevent recurrent hepatic encephalopathy 6. The onset of hepatic encephalopathy predicts a 1-yr survival of 40%

84. ENLmedical.com: Conditions And Concerns: Medical Encyclopedia: Hepatic Encephalo Table of content. hepatic encephalopathy. Causes and Risks Hepaticencephalopathy is caused by disorders affecting the liver. These http://www.enlmedical.com/article/000302.htm

Medical Dictionary Naturapathic Glossary Aphrodisiacs Immune System ... Table of content Hepatic Encephalopathy Causes and Risks: Hepatic encephalopathy is caused by disorders affecting the liver. These include disorders that reduce liver function (such as cirrhosis or hepatitis ) and conditions where blood circulation bypasses the liver. The exact cause of the disorder is unknown. The liver cannot properly metabolize and detoxify substances in the body. Accumulation of toxic substances causes metabolic abnormalities that lead to damage in the central nervous system (brain and spinal cord). The most common toxic substance is ammonia , which is produced by the body when proteins are digested, but normally is detoxified by the liver. Many other substances also accumulate in the body and damage the nervous system. In people with otherwise stable liver disorders, hepatic encephalopathy may be triggered by episodes of gastrointestinal bleeding, excessive dietary protein , or electrolyte abnormalities (especially decrease in potassium, which may result from vomiting or treatments such as diuretics or paracentesis ). The disorder may also be triggered by any condition that results in

85. Hepatic Encephalopathy Spanish hepatic encephalopathy. Causes, incidence, and risk factors Hepaticencephalopathy is caused by disorders affecting the liver. These http://www.umm.edu/ency/article/000302.htm

Disease Nutrition Surgery Symptoms Injury ... Encyclopedia (English) Toggle English Spanish Hepatic encephalopathy Overview Symptoms Treatment Prevention Definition: A group of symptoms that may occur when there is damage to the brain and nervous system as a complication of liver disorders, characterized by various neurologic symptoms including changes in reflexes, changes in consciousness , and behavior changes that can range from mild to severe. Alternative Names: Hepatic coma; Encephalopathy - hepatic Causes, incidence, and risk factors: Hepatic encephalopathy is caused by disorders affecting the liver. These include disorders that reduce liver function (such as cirrhosis or hepatitis ) and conditions where blood circulation bypasses the liver. The exact cause of the disorder is unknown. The liver cannot properly metabolize and detoxify substances in the body. Accumulation of toxic substances causes metabolic abnormalities that lead to damage in the central nervous system (brain and spinal cord). One substance believed to be toxic is ammonia , which is produced by the body when proteins are digested, but normally is detoxified by the liver. Many other substances also accumulate in the body and damage the nervous system.

86. Health Ency.: Disease: Hepatic Encephalopathy hepatic encephalopathy. Treatment. hepatic encephalopathy is an acute medicalcondition that may become a medical emergency. Hospitalization is required. http://www.accessatlanta.com/shared/health/adam/ency/article/000302trt.html

SEARCH: The Web Yellow Pages HOME AJC.COM Illustrated Health Encyclopedia Important notice Ency. home Disease H Hepatic encephalopathy Overview Symptoms Treatment Prevention Alternative names: Hepatic coma; Encephalopathy - hepatic Treatment Hepatic encephalopathy is an acute medical condition that may become a medical emergency. Hospitalization is required. The goals of treatment include life support, elimination or treatment of precipitating factors, and removal or neutralization of ammonia and other toxins . Life support including support of breathing or circulation may be required, particularly if coma develops. Cerebral edema (brain swelling ) may occur and may be life-threatening. Precipitating factors must be identified and treated. Gastrointestinal bleeding must be stopped. The intestines must be emptied of blood. Blood breaks down into protein components that are converted to ammonia. Treatment of infections, renal failure, and electrolyte abnormalities (especially potassium) are important. The patient should reduce or eliminate protein in diet to reduce ammonia production. Vegetable protein may be tolerated better than animal protein. Specially formulated

87. Health Ency.: Disease: Hepatic Encephalopathy hepatic encephalopathy. Alternative names Hepatic coma; Encephalopathy hepatic. Prevention. Treatment of liver disorders, particularly http://www.accessatlanta.com/shared/health/adam/ency/article/000302prv.html

SEARCH: The Web Yellow Pages HOME AJC.COM Illustrated Health Encyclopedia Important notice Ency. home Disease H Hepatic encephalopathy Overview Symptoms Treatment Prevention Alternative names: Hepatic coma; Encephalopathy - hepatic Prevention Treatment of liver disorders, particularly when that treatment includes restriction of dietary protein (a primary source of ammonia ), may prevent some cases of hepatic encephalopathy. Any neurologic symptoms in a person with known or suspected liver disease should be referred to the health care provider immediately. Ency. home Disease H Please read this Important notice Also Check Out Subscribe to The Atlanta Journal-Constitution Home Autos Classifieds ... Our Sponsors By using AccessAtlanta.com you accept the terms of our Visitor Agreement . Please read it. Privacy statement Registered site users: edit your profile

88. VetMedCenter - Consumer - Article Details Brain Disorder Secondary to Liver Disease (hepatic encephalopathy). UnderstandingYour Pet's Medical Diagnosis What is hepatic encephalopathy? http://www.vetmedcenter.com/consumer/display.asp?fn=P-MR-M-Nu_5-HepEnceph1XX.xml

89. Stages Of Hepatic Encephalopathy The summary for this Chinese (Traditional) page contains characters that cannot be correctly displayed in this language/character set. http://www.vghtc.gov.tw:8082/ped/teaching/GI/ful hepatitis/sld009.htm

§ë¼v¤ù 9 ¤§ 12

90. Dr. Clarke Cushing My kitten has hepatic encephalopathy. What causes this? Category Feline. Theveterinarian suspects hepatic encephalopathy. What is this? http://www.lclarkecushingvmd.com/showpracfaq.cfm?FAQID=12&Private=0

91. Felipo's Curriculum Cirrhosis, hepatic encephalopathy and ammonium toxicity In Advances inExperimental Medicine and Biology. Vol. 272, 1990, Plenum Press. New York. http://www.ochoa.fib.es/Investigadores/Felipo/felipcuri.htm

Vicente Felipo. CURRICULUM VITAE Name: Vicente Felipo Born the 12 of May, 1957 at Tabernes Blanques, Valencia, Spain Married Home address: Rey Don Jaime 2-1-B. Tabernes Blanques, 46016 Valencia. Spain Work address: Instituto de Investigaciones Citologicas Amadeo de Saboya, 4 46010 Valencia Spain Telephone: Fax: email: vfelipo@ochoa.fib.es Chemist, Universtiy of Valencia, Spain, June 1979 Doctor (Ph. D.) in Biochemistry, University of Valencia, October 1983 Possition: EDITORIAL WORK: Member of the Editorial Board of the journals: - Neurochemical Research, 1993 - - Metabolic Brain Disease 1994 - - Analytical Pharmacology 1997 - - International Journal of Molecular Medicine 1997 - Editor of the following books - "Cirrhosis, hepatic encephalopathy and ammonium toxicity" In: Advances in Experimental Medicine and Biology. Vol. 272, 1990, Plenum Press. New York - "Cirrhosis, hyperammonemia and hepatic encephalopathy" In: Advances in Experimental Medicine and Biology. Vol. 341, 1993. Plenum Press, New York. - "Hepatic encephalopathy, hyperammonemia and ammonia toxicity" In: Advances in Experimental Medicine and Biology. Vol. 368, 1995. Plenum Press, New York.

92. Small Animal Clinical Services hepatic encephalopathy. hepatic encephalopathy has been recognized in animals withPSS, endstage liver disease, and congenital urea cycle enzyme deficiencies. http://www.vet.utk.edu/clinical/sacs/shunts_pathophysiology.html

Anesthesia and Intensive Care Cardiology Clinical Behavior Science Dermatology ... Radiation Oncology Pathophysiology Karen M. Tobias , DVM, MS, Diplomate ACVS Table of Contents: Information for Pet Owners: FAQs Introduction Pathophysiology Hepatic Encephalopathy ... Printer-friendly version - .pdf 103 KB Pathophysiology Clinical signs associated with portosystemic shunts commonly involve the nervous system, gastrointestinal tract, and urinary tract.  General clinical signs include poor growth rate, weight loss, fever, and anesthetic or tranquilizer intolerance.  Neurologic dysfunction is seen in most animals with PSS and includes lethargy and depression, ataxia, seizures, behavioral changes, and blindness.   Head pressing, circling, and development of a head tilt have also been reported.  Gastrointestinal clinical abnormalities include anorexia, vomiting, and diarrhea. Some dogs have no apparent signs or present with signs of cystitis or urinary tract obstruction. Many cats have hypersalivation and some have unusual copper colored irises. Hepatic histologic changes in animals with PSS include generalized congestion of central veins and sinusoids, lobular collapse, bile duct proliferation, hypoplasia of intrahepatic portal tributaries, proliferation of small vessels and lymphatics, diffuse fatty infiltration, hepatocellular atrophy, and cytoplasmic vacuolization. These pathology changes can also be seen in dogs with hepatic microvascular dysplasia that do not have single congneital shunts.  Pathologic changes may be present in the central nervous system, especially in encephalopathic animals.

93. Benzodiazepine Receptor Antagonists For Acute And Chronic Hepatic Encephalopathy All rights reserved. Benzodiazepine receptor antagonists for acute and chronic hepaticencephalopathy (Cochrane Review). AlsNielsen B, Kjaergard LL, Gluud C. http://www.update-software.com/abstracts/ab002798.htm

From The Cochrane Library, Issue 1, 2003 Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy (Cochrane Review) Als-Nielsen B, Kjaergard LL, Gluud C ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... About The Cochrane Library A substantive amendment to this systematic review was last made on 10 July 2001. Cochrane reviews are regularly checked and updated if necessary. Background: The pathogenesis of hepatic encephalopathy is unknown. It has been suggested that liver failure leads to the accumulation of substances that bind to a receptor-complex in the brain resulting in neural inhibition which may progress to coma. Several trials have assessed benzodiazepine receptor antagonists for hepatic encephalopathy, but the results are conflicting. Objectives: To evaluate the efficacy and safety of benzodiazepine receptor antagonists for patients with acute or chronic hepatic encephalopathy. Search strategy: Eligible trials were identified through The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Controlled Trials Register on The Cochrane Library (Issue 2, 2001), MEDLINE and EMBASE (last searched: June 2001), reference lists of relevant articles, authors of trials, and the pharmaceutical company known to produce benzodiazepine receptor antagonists. Selection criteria: Randomised trials comparing any benzodiazepine receptor antagonist versus placebo or no intervention for hepatic encephalopathy were included, regardless of language or publication status.

94. Correlation Between Arterial Ammonia And Grade Of Hepatic Encephalopathy Translate this page Folie 19 von 21 Notizen Hier sehen Sie, dass Schweregrad und arteriellerAmmoniak korrelieren. Es besteht jedoch eine gehörige http://www.ikp.unibe.ch/lab2/Pp/Pp8/sld019.htm

Folie 19 von 21 Notizen: Hier sehen Sie, dass Schweregrad und arterieller Ammoniak korrelieren. Es besteht jedoch eine gehörige Überlappung zwischen den Gruppen und sowohl in Grad I und II kann das Ammoniak noch normal sein.

95. Correlation Between Arterial Ammonia And Grade Of Hepatic Encephalopathy Translate this page Correlation between arterial ammonia and grade of hepaticencephalopathy. C. o. m. a. g. r. a. d. e. I. I. I. I.I. I. I. V. http://www.ikp.unibe.ch/lab2/Pp/Pp8/tsld019.htm

Correlation between arterial ammonia and grade of hepatic encephalopathy C o m a g r a d e I I I I I I I V Vorherige Folie Nächste Folie Zurück zur ersten Folie Graphik-Version anzeigen Notes: Hier sehen Sie, dass Schweregrad und arterieller Ammoniak korrelieren. Es besteht jedoch eine gehörige Überlappung zwischen den Gruppen und sowohl in Grad I und II kann das Ammoniak noch normal sein.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 5     81-95 of 95    Back | 1  | 2  | 3  | 4  | 5